Fesoterodine Dose Response in Subjects with Overactive Bladder Syndrome (vol 71, pg 839, 2008)

被引：0
|
作者：
Khullar, Vik
Rovner, Eric S.
Dmochowski, Roger
Nitti, Victor
Wang, Joseph
Guan, Zhonghong
机构：
来源：
UROLOGY | 2009年 / 74卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [41] Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms
    Van Kerrebroeck, P. E. V.
    Heesakkers, J.
    Berriman, S.
    Aiyer, L. Padmanabhan
    Carlsson, M.
    Guan, Z.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 584 - 593
  • [42] Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Nonresponders
    Khusid, Johnathan A.
    Weiss, Jeffrey P.
    Carlsson, Martin O.
    Mangan, Erin K.
    [J]. JOURNAL OF UROLOGY, 2017, 198 (05): : 1119 - 1123
  • [43] Effect of treatment response on the decision to escalate antimuscarinic dose in elderly subjects with overactive bladder
    Wagg, A.
    Khullar, V
    Oelke, M.
    Marschall-Kehrel, D.
    Michel, M. C.
    Darekar, A.
    Ebel-Bitoun, C.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E578 - U241
  • [44] Redefining response in overactive bladder syndrome
    Payne, Christopher K.
    Kelleher, Con
    [J]. BJU INTERNATIONAL, 2007, 99 (01) : 101 - 106
  • [45] A pilot study of fesoterodine in the management of men with refractory overactive bladder symptoms after surgery for bladder outlet obstruction (vol 26, pg 38, 2015)
    Chughtai, Bilal
    Laudano, Melissa
    Dunphy, Claire
    Lee, Richard
    Kaplan, Steven A.
    Te, Alexis
    [J]. UROLOGICAL SCIENCE, 2015, 26 (02) : 147 - 147
  • [46] FESOTERODINE 4 MG ONCE DAILY IMPROVED OVERACTIVE BLADDER SYMPTOMS IN SUBJECTS DISSATISFIED WITH TOLTERODINE TREATMENT
    Wyndaele, J-J
    Goldfischer, E. G.
    Morrow, J. D.
    Gong, J.
    Tseng, L. J.
    Guan, Z.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 167 - 167
  • [47] Fesoterodine vs Tolterodine for Overactive Bladder in Older Subjects: Effect of Baseline Urgency Urinary Incontinence Severity
    Lee, R.
    Zou, K. H.
    Bavendam, T.
    Trocio, J.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S124 - S125
  • [48] Fesoterodine significantly improves treatment response rate in subjects with overactive bladder as early as 2 weeks: Subpopulation analyses of a phase III trial
    Tubaro, A.
    Staskin, D.
    Nitti, V.
    Bavendam, T.
    Wang, J. T.
    Trocio, J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 239 - 239
  • [49] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLEXIBLE-DOSE FESOTERODINE FOR OVERACTIVE BLADDER
    Staskin, David R.
    Peters, Kenneth M.
    Morrow, Jon D.
    Guan, Zhonghong
    Gong, Jason
    Sun, Franklin
    Siami, Paul F.
    Dmochowski, Roger R.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2009, 28 (02) : 145 - 145
  • [50] EFFICACY AND TOLERABILITY OF FESOTERODINE FUMARATE IN THE TREATMENT OF OVERACTIVE BLADDER SYNDROME IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS
    Silvia, Proietti
    Emanuele, Lepri
    Luca, Lepri
    Carolina, Lolli
    Marilena, Gubbiotti
    Antonella, Giannantoni
    [J]. NEUROUROLOGY AND URODYNAMICS, 2012, 31 : S30 - S31
12345